These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9229190)

  • 1. Lipid peroxidation in type 2 normolipidemic diabetic patients.
    Freitas JP; Filipe PM; Rodrigo FG
    Diabetes Res Clin Pract; 1997 May; 36(2):71-5. PubMed ID: 9229190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides.
    Guerci B; Antebi H; Meyer L; Durlach V; Ziegler O; Nicolas JP; Alcindor LG; Drouin P
    Clin Chem; 1999 Sep; 45(9):1439-48. PubMed ID: 10471646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease.
    Dyer RG; Stewart MW; Mitcheson J; George K; Alberti MM; Laker MF
    Clin Chim Acta; 1997 Apr; 260(1):1-13. PubMed ID: 9101096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lipid peroxidation in type 2 poorly controlled diabetic patients.
    Altomare E; Vendemiale G; Chicco D; Procacci V; Cirelli F
    Diabete Metab; 1992; 18(4):264-71. PubMed ID: 1459313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycosylation and lipid peroxidation in skin and in plasma in diabetic patients].
    Freitas JP; Filipe P; Guerra Rodrigo F
    C R Seances Soc Biol Fil; 1997; 191(5-6):837-43. PubMed ID: 9587489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo.
    Kostner K; Banyai S; Jansen M; Khoschsorur G; Hörl WH; Maurer G; Winklhofer-Roob B; Derfler K
    Clin Chim Acta; 1999 Oct; 288(1-2):21-30. PubMed ID: 10529454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia.
    Nacítarhan S; Ozben T; Tuncer N
    Free Radic Biol Med; 1995 Dec; 19(6):893-6. PubMed ID: 8582665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats.
    Ihm SH; Yoo HJ; Park SW; Ihm J
    Metabolism; 1999 Sep; 48(9):1141-5. PubMed ID: 10484054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased low-density lipoprotein peroxidation in elderly men.
    Napoli C; Abete P; Corso G; Malorni A; Postiglione A; Ambrosio G; Cacciatore F; Rengo F; Palumbo G
    Coron Artery Dis; 1997; 8(3-4):129-36. PubMed ID: 9237021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients.
    Rabini RA; Fumelli P; Galassi R; Dousset N; Taus M; Ferretti G; Mazzanti L; Curatola G; Solera ML; Valdiguié P
    Metabolism; 1994 Dec; 43(12):1470-4. PubMed ID: 7990698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes.
    Ohmura C; Watada H; Azuma K; Shimizu T; Kanazawa A; Ikeda F; Yoshihara T; Fujitani Y; Hirose T; Tanaka Y; Kawamori R
    Endocr J; 2009; 56(1):149-56. PubMed ID: 18997444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation and catalase in diabetes mellitus with and without ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M; Lazăr L; Drută A
    Rom J Intern Med; 2004; 42(2):423-9. PubMed ID: 15529632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
    Katoh K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and lipoprotein lipid peroxidation in humans on sunflower and rapeseed oil diets.
    Turpeinen AM; Alfthan G; Valsta L; Hietanen E; Salonen JT; Schunk H; Nyyssönen K; Mutanen M
    Lipids; 1995 Jun; 30(6):485-92. PubMed ID: 7651074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia.
    Ceriello A; Bortolotti N; Motz E; Pieri C; Marra M; Tonutti L; Lizzio S; Feletto F; Catone B; Taboga C
    Metabolism; 1999 Dec; 48(12):1503-8. PubMed ID: 10599980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N; Kashiwagi A; Nishio Y; Kikkawa R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high monounsaturated and polyunsaturated fat diets on plasma lipoproteins and lipid peroxidation in type 2 diabetes mellitus.
    Parfitt VJ; Desomeaux K; Bolton CH; Hartog M
    Diabet Med; 1994; 11(1):85-91. PubMed ID: 8181259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.